PALI - Palisade Bio, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
1.89 -0.14 (-7.41%)	---	---	0.01 (0.59%)	-0.04 (-2.12%)	-0.1 (-5.72%)	0.02 (1.16%)	0.02 (1.16%)

Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: Closed

Earnings & Ratios

Basic EPS:: -0.58
Diluted EPS:: -0.58
Basic P/E:: -3.0172
Diluted P/E:: -3.0172
RSI(14) 1m:: 100.0
VWAP:: 1.75
RVol:: 0.3493

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	1.73 -0.02 (-1.14%)	Oct 15 17:42
1m	Price decrease 1m	1.73 -0.02 (-1.15%)	Oct 15 15:58
1m	Price increase 1m	1.73 +0.02 (+1.17%)	Oct 15 15:28
1m	Price increase 1m	1.75 +0.02 (+1.19%)	Oct 15 14:59
1m	Price decrease 1m	1.77 -0.02 (-1.12%)	Oct 15 14:01